ArticleFrontiers in immunology2026
Effects of Batri-7 on fallopian tube tissues in a rat model of salpingitis based on the toll-like receptor 4/myeloid differentiation factor 88/nuclear factor kappa B signalling pathway.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to explore the underlying mechanism of Batri-7 in tubal inflammatory infertility model rats treatment in the toll-like receptor 4 (TLR4)/myeloid differentiation factor 88 (MyD88)/nuclear factor kappa B (NF-κB) pathway. Methods: Fifty-three specific-pathogen-free-grade female Sprague-Dawley rats were selected, of which 10 were randomly assigned to the blank control group (normal rats). The remaining 43 rats were used to establish a salpingitis model, induced by mixed bacteria, and were randomly divided into a model group, a positive control group, a low-dose experimental group and a high-dose experimental group. The rats in the blank and model groups were gavaged with 10 mL·kg Results: Compared with the model group, the high-dose experimental group, the low-dose experimental group and the positive control group could significantly reduce the expression levels of IL-1β, ICAM-1 and TNF-α in plasma, increase the expression level of IL-10 ( Conclusion: Batri-7 can exert anti-inflammatory effects and treat salpingitis by regulating the TLR4/MyD8/NF-κB signalling pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.